Published in Zentralbl Bakteriol Mikrobiol Hyg A on April 01, 1985
Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes. Appl Environ Microbiol (2003) 1.38
Quorum sensing in group A Streptococcus. Front Cell Infect Microbiol (2014) 0.89
Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis. Infect Dis Obstet Gynecol (2003) 0.81
Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: Potential significance in bacterial vaginosis. Microb Ecol Health Dis (2007) 0.78
Inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes bacteriocinlike inhibitory substance. J Clin Microbiol (1991) 0.75
Bacteriocins of gram-positive bacteria. Bacteriol Rev (1976) 10.66
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
Assay system for bacteriocins. Appl Microbiol (1971) 3.05
Dental caries is a preventable infectious disease. Aust Dent J (2000) 1.98
"Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol (1979) 1.97
Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med (1973) 1.89
Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol (2001) 1.63
Bacteriocin of a group B streptococcus: partial purification and characterization. Antimicrob Agents Chemother (1975) 1.59
Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microbiol (1993) 1.56
Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob Agents Chemother (1973) 1.54
A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol (2006) 1.54
Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl Environ Microbiol (1993) 1.36
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis. J Med Microbiol (2000) 1.24
Contrasts in tick innate immune responses to Borrelia burgdorferi challenge: immunotolerance in Ixodes scapularis versus immunocompetence in Dermacentor variabilis (Acari: Ixodidae). J Med Entomol (2001) 1.20
Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidemiol Infect (1987) 1.16
Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes. FEMS Microbiol Lett (1999) 1.15
Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol (2011) 1.13
Novel lantibiotics and their pre-peptides. Antonie Van Leeuwenhoek (1996) 1.12
An inhibitor typing scheme for Streptococcus uberis. J Dairy Res (1986) 1.12
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 1. Pyocine typing of Ps. aeruginosa. Med J Aust (1971) 1.12
Genotypic and phenotypic analysis of Streptococcus uberis isolated from bovine mammary secretions. Epidemiol Infect (1991) 1.09
A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes. Dev Biol Stand (1995) 1.09
Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis (2008) 1.08
Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J Med Microbiol (1979) 1.06
A novel approach to controlling bacterial contamination on toothbrushes: chlorhexidine coating. Int J Dent Hyg (2009) 1.05
Identification of a defensin from the hemolymph of the American dog tick, Dermacentor variabilis. Insect Biochem Mol Biol (2001) 1.05
Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg (Lond) (1983) 1.04
Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages. J Med Microbiol (2002) 1.04
Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin. FEMS Microbiol Lett (2000) 1.03
Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Arch Oral Biol (1983) 1.03
Factors affecting production of the group A streptococcus bacteriocin SA-FF22. J Med Microbiol (1992) 1.03
Genetic basis of streptococcin A-FF22 production. Antimicrob Agents Chemother (1976) 1.02
Response of the tick Dermacentor variabilis (Acari: Ixodidae) to hemocoelic inoculation of Borrelia burgdorferi (Spirochetales). J Med Entomol (2000) 1.00
The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch Oral Biol (1982) 1.00
Transduction of bacteriocin determinants in group A streptococci. J Exp Med (1976) 0.99
Some possible autoimmune mechanisms in rheumatic carditis. Lancet (1972) 0.99
Immunologic cross-reactivity of type A streptococcal exotoxin (erythrogenic toxin) and staphylococcal enterotoxins B and C1. Infect Immun (1987) 0.98
Control of bacterial infections in the hard tick Dermacentor variabilis (Acari: Ixodidae): evidence for the existence of antimicrobial proteins in tick hemolymph. J Med Entomol (1998) 0.97
Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrob Agents Chemother (1978) 0.97
The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis (2005) 0.97
Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology (2011) 0.97
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun (1999) 0.95
M-type 57 group A streptococcus bacteriocin. Can J Microbiol (1983) 0.95
Inhibitor production by group-G streptococci of human and of animal origin. J Med Microbiol (1983) 0.95
Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol (1996) 0.92
Beneficial microbes for the oral cavity: time to harness the oral streptococci? Benef Microbes (2011) 0.92
Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol Lett (1992) 0.91
Role of bacteriocin during plaque formation by Streptococcus salivarius and Streptococcus sanguis on a tooth in an artificial mouth. J Appl Bacteriol (1981) 0.90
Enhancement of OspC expression by Borrelia burgdorferi in the presence of tick hemolymph. FEMS Microbiol Lett (2000) 0.90
Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types. J Clin Microbiol (1984) 0.89
Use of an inhibitor typing scheme to study the epidemiology of Streptococcus uberis mastitis. N Z Vet J (1988) 0.88
Suspected periodontopathic microorganisms and their oral habitats in young children. Oral Microbiol Immunol (1987) 0.88
Bacteriocin production by group a streptococcal L-forms. Antimicrob Agents Chemother (1976) 0.87
Morphological changes in a susceptible strain of Streptococcus pyogenes treated with streptocin A. J Gen Microbiol (1973) 0.86
Bacteriocin-like inhibitory activity associated with beta-hemolytic strains of Streptococcus salivarius. J Dent Res (1987) 0.86
Genetic basis for mutacin N and of its relationship to mutacin I. Indian J Med Res (2004) 0.84
Bacteriocin production and sensitivity among coaggregating and noncoaggregating oral streptococci. Oral Microbiol Immunol (1997) 0.84
Proteinase-related broad-spectrum inhibitory activity among group-A streptococci. J Med Microbiol (1986) 0.84
A bacteriocin produced by certain M-type 49 Streptococcus pyogenes strains when incubated anaerobically. J Hyg (Lond) (1984) 0.83
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 2. "Fingerprinting" of Ps. aeruginosa strains in a study of cross-infection in a children's hospital. Med J Aust (1971) 0.83
A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius. J Clin Microbiol (2000) 0.82
Heart-reactive antibodies in rheumatic fever. Med J Aust (1972) 0.82
Pyocine typing as an epidemiological marker in Pseudomonas aeruginosa mastitis in cattle. J Hyg (Lond) (1971) 0.81
High pharyngeal carriage rates of Streptococcus pyogenes in Dunedin school children with a low incidence of rheumatic fever. N Z Med J (2000) 0.81
Tissue and life-stage distribution of a defensin gene in the Lone Star tick, Amblyomma americanum. Med Vet Entomol (2007) 0.81
Relationship of bacteriocin-like inhibitor production to the pigmentation and hemolytic activity of mutans streptococci. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.80
Suspected periodontopathic bacteria associated with broken-mouth periodontitis in sheep. J Periodontal Res (1988) 0.80
Microbially-produced peptides having potential application to the prevention of dental caries. Int J Antimicrob Agents (1997) 0.79
The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci. N Z Dent J (1991) 0.78
Bacteriocin production by Streptococcus salivarius strain P. Can J Microbiol (1981) 0.78
Myoid cell antibody in rheumatic fever. Immunol Commun (1973) 0.77
Evaluation of stored lamb bio-preserved using a three-strain cocktail of Lactobacillus sakei. Meat Sci (2010) 0.77
Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci. Caries Res (2001) 0.77
Black-pigmented Bacteroides associated with broken-mouth periodontitis in sheep. J Periodontal Res (1987) 0.77
Pyocin-sensitivity testing as a means of typing Pseudomonas aeruginosa. J Med Microbiol (1973) 0.77
Evaluation of a typing scheme for group A streptococci based upon bacteriocin-like inhibitor production. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.77
Role of proteinase in the formation of inhibitory levels of hematin by group A streptococcus cultures on blood-containing media. J Clin Microbiol (1986) 0.75
Streptolysin S: purification and properties. Zentralbl Bakteriol Orig A (1978) 0.75
Incidence and characterization of anti-microbial effects produced by Actinomyces viscosus and Actinomyces naeslundii. J Dent Res (1986) 0.75
Commensal bacilli inhibitory to mastitis pathogens isolated from the udder microbiota of healthy cows. J Appl Microbiol (2006) 0.75
Environmental influences on the progression of clinical and microbiological parameters of sheep periodontal disease. Res Vet Sci (1989) 0.75
Quantification of the bacterium Bacteroides gingivalis in human dental plaque by detection of the trypsin-like protease activity of colonies imprinted on membrane filters. Arch Oral Biol (1987) 0.75
An inhibitor typing scheme applicable to Lancefield group E streptococci. Can J Microbiol (1985) 0.75
Bacterial interference and toxic shock syndrome. Ann Intern Med (1983) 0.75
Toxic shock syndrome. N Z Med J (1987) 0.75